Immunopathology of hepatitis C

Springer Seminars in Immunopathology

Volumn 19, Issue 1, 1997, Pages 57-68

  Chang, Kyong Mi ^a   Rehermann, Barbara ^b   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; CHRONIC HEPATITIS; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS PATHOGENESIS;

AMINO ACID SEQUENCE; EPITOPES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HEPATITIS, CHRONIC; HLA-A2 ANTIGEN; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030846627     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00945025     Document Type: Review

References (79)

1. Alter HJ (1995) To C or not to C: these are the questions. Blood 85:1681
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ, the Sentinel Counties Chronic Non-A Non-B Hepatitis Study Team (1992) The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899
3. Autran B, Hadida F, Haas G (1996) Evolution and plasticity of CTL responses against HIV. Curr Opin Immunol 8:546
4. Bach N, Thung SN, Schaffner F (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15:572
5. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Albeti A, Bianchi FB (1995) Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. J Clin Invest 95:2067
6. Barbatis C, Woods J, Morton JA, Fleming KA, McMichael A, McGee JO (1981) Immunohistochemical analysis of HLA (A,B,C) antigens in liver disease using a monoclonal antibody. Gut 22:985
7. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching W-M, Grakoui A, Rice CM, Kurokohchi K, Berzofsky JA, Hoofnagle JH, Feinstone SM, Akatsuka T (1995) Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 69:2452
8. Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, Guilhot S, Chisari FV (1991) HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 88:10445
9. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, DeCarli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407
10. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo Q-L, Shuster JR, Kuo G, Bonino F, Houghton M, Abrignani S (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580
11. Bukh J, Miller RH, Purcell RH (1995) Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15:41
12. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM (1996) Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreatment with interferon alpha. Hepatology 24:6
13. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521
14. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359
15. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A (1989) Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 321:1501
16. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989) Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 321:1506
17. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C (1995) Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 96:224
18. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakimi T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996) Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77
19. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM (1993) Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 151:4189
20. Esteban JI, Esteban R, Viladomiu L, Lopez-Talvera JC, Gonzalez A, Hernandez J (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet 11:294
21. Falk K, Roetzschke O, Stevanovic S, Jung G, Rammensee H-G (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290
22. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135
23. Feinstone SM, Mihalik KB, Kamimura T, Alter HJ, London WT, Purcell RH (1983) Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun 41:816
24. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Guiberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F (1994) T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286
25. Franco A, Ferrari C, Sette A, Chisari FV (1995) Viral mutations, T cell receptor antagonism and escape from the immune response. Curr Opin Immunol 7:524
26. Gretch DR, Bacchi CE, Corey L, Rosa CD, Lesniewski RR, Kowdley K, Gown A, Frank I, Perkins JD, Carithers RL (1995) Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 22:1
27. Guidotti LG, Chisari FV (1996) To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 8:478 483
28. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25
29. He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH (1987) Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 156:636
30. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RP, Yoshikura H (1993) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67:1953
31. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, Fuke I, Okayama H, Kamada T (1992) Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 16:306
32. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T (1994) Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354
33. Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, Ohnishi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M (1997) Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25:705
34. Hoffmann RM, Diepolder HM, Zachoval R, Zweibel F-M, Jung M-C, Scholz S, Nitschko H, Riethmuller G, Pape GR (1995) Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus and their relevance during the course of chronic infection. Hepatology 21:632
35. Hollinger FB (1990) Hepatitis B virus. In: Fields BN, et al (eds) Virology. Raven Press, New York, pp 2171-2236
36. Imawari M, Nomura M, Kaieda T, Moriyama T, Oshimi K, Nakamura I, Gunji T, Ohnishi S, Ishikawa T, Nakagama H, Takaku F (1989) Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus. Proc Natl Acad Sci USA 86:2883
37. Kast WM, Brandt RMP, Sidney J, Drijfhout J-W, Kubo RT, Grey HM, Melief CJM, Sette A (1994) The role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol 152:3904
38. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M (1993) HLA-B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039
39. Kiyosawa K, Akahane Y, Nagata A, Koike Y, Furuta S (1982) Significance of blood transfusion in non-A, non-B chronic liver disease in Japan. Vox Sang 43:45
40. Klenerman P, Rowland-Jones S, McAdams S, Edwards J, Daenke S, Lalloo D, Koppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, McMichael AJ (1994) Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403
41. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, Iino S, Kurokawa K, Miyamura T (1995) Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 76:3031
42. Kolykhalov AA, Feinstone SM, Rice CM (1996) Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 70:3363
43. Koup RA (1994) Virus escape from CTL recognition. J Exp Med 180:779
44. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339
45. Koziel MJ, Dudley D, Afdhal N, Choo Q-L, Houghton M, Ralston R, Walker BD (1993) Hepatitis C virus (HCV)-specific cytoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522
46. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo Q-L, Houghton M, Walker BD (1995) HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96:2311
47. Kuo G, Choo Q-L, Alter HJ, Gitnick GI, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Syevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton MA (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362
48. Matsuura Y, Miyamura T (1993) The molecular biology of hepatitis C virus. Semin Virol 4:297
49. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C (1996) Differential clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98:706
50. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T (1994) Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204:468
51. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV (1990) Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248:361
52. Nagata S (1996) Fas ligand and immune evasion. Nature Med 2:1306
53. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th 1-associated cytokines. Hepatology 24:759
54. Nayersina R, Folwer P, Guilhot S, Missale G, Cerny A, Schlicht H-J, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV (1993) HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 150:4659
55. Noun-Aria KT, Sallie R, Mizokami M, Portmann BC, Williams R (1995) Intrahepatic expression of hepatitis C virus antigens in chronic liver disease. J Pathol 175:77
56. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdams S, Klenerman P, Koppe B, Sigmund K, Bangham CRM (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606
57. Ogata N, Alter HJ, Miller RH, Purcell RH (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88:3392
58. Pasquinelli C, Shoenberger JM, Chung J-S, Chang K-M, Selby M, Berger K, Lesniewski R, Houghton M, Chisari FV (1997) Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 25:719
59. Pereira BJG, Milford EL, Kirkman RL, Levey AS (1991) Transmission of hepatitis C virus by organ transplantation. N Engl J Med 325:454
60. Peters CJ, Buchmeier M, Rollin PE, Ksiazek TG (1996) Arenaviruses. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology. Lippincott-Raven Press, Philadelphia, pp. 1521
61. Rehermann B, Person J, Redeker A, Fowler P, Brown M, Moss B, Sette A, Chisari FV (1995) The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 181:1047
62. Rehermann B, Chang K-M, McHutchison JG, Kokka R, Houghton M, Chisari FV (1996) Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432
63. Rehermann B, Chang K-M, McHutchison JG, Kokka R, Houghton M, Rice CM, Chisari FV (1996) Differential cytotoxic T lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70:7092
64. Rehermann B, Lau D, Hoofnagle JH, Chisari FV (1996) Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 97:1655
65. Resnick RH, Koff R (1993) Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch Intern Med 153:1672
66. Rickinson AB, Lee SP, Steven NM (1996) Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr Opin Immunol 8:492
67. Scheuer P, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM (1992) The pathology of hepatitis C. Hepatology 15:567
68. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68:1494
69. Smith GL (1996) Virus proteins that bind cytokines, chemokines or interferons. Curr Opin Immunol 8:467
70. Spriggs MK (1996) One step ahead of the game: viral immunomodulatory molecules. Ann Rev Immunol 14:101
71. Stevens CE, Taylor CE, Pindyk J, Choo Q-L, Bradley DW, Kuo G, Houghton M (1990) Epidemiology of hepatitis C virus. JAMA 263:49
72. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nature Med 2:1361
73. Tanaka T, Kato N, Cho M-J, Sugiyama K, Shimotohno K (1996) Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 70:3307
74. Thomssen R, Bonk S, Propfe C, Heermann K-H, Kochel HG, Uy A (1992) Association of hepatitis C virus in human sera with B-lipoprotein. Med Microbiol Immunol 181:293
75. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchison JG, Houghton M (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci USA 89:3468
76. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 92:2755
77. Wong D, Koziel M, Dudley D, Afdhal N, Rice C, Houghton M, Walker B (1996) Hepatitis C virus-specific cytotoxic T lymphocytes from liver and peripheral blood. Abstracts of the IX Triennial International Symposium on Viral Hepatitis and Liver Disease, Italy, 1996, CpA, Rome, abstr. no. 38
78. Yoo JY, Howard R, Waggoner JG, Hoofnagle JH (1987) Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis. J Med Virol 23:273
79. Yuasa T, Ishikawa G, Manabe S, Sekiguchi S, Takeuchi K, Miyamura T (1991) The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J Gen Virol 72:2021